Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection

Gene Therapy

Volumn 7, Issue 7, 2000, Pages 605-611

  Benvenuti, F ^a   Burrone, O R ^a   Efremov, D G ^b  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

DNA vaccination; Lymphoma immunotherapy; Single chain Fv

Indexed keywords

ANTIBODY; DNA VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE CONSTRUCT; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SURVIVAL; VACCINATION;

ANIMALIA; MURINAE;

EID: 0034022050     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301133     Document Type: Article

References (27)

1. Lynch RG et al. Myeloma proteins as tumor specific transplantation antigens. Proc Natl Acad Sci USA 1972; 69: 1540-1544.
2. Campbell M et al. Idiotypc vaccination against murine B cell lymphoma: humoral and cellular responses elicited by tumor derived IgM and its molecular subunits. J Immunol 1987; 139: 2825-2833.
3. Kaminski MS, Kitamura K, Maloney DG, Levy R. Idiotype vaccination against murine B cell lymphoma: inhibition of tumor immunity by free idiotype protein. J Imnnmol 1987; 138: 1289-1296.
4. George AJT, Folkard SG, Hamblin TJ, Stevenson FK. Idiotypic vaccination as a treatment for a B cell lymphoma. J Immunol 1988; 141: 2168-2174.
5. Kwak LW et al. Induction of immune responses in patient with B cell lymphoma against the surface-immunoglobulin expressed by their tumors. New Engl J Med 1992; 327: 1209-1215.
6. Hsu FJ et al. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma - long-term results of a clinical trial. Blood 1997; 89: 3129-3135.
7. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Annu Rev Immunol 1997; 15: 617-648.
8. Stevenson FK et al. Idiotypic DNA vaccines against B cell lymphoma. Immunol Rev 1995; 145: 211-228.
9. Syrengelas AD, Chen TT, Levy R. DNA immunization induces protective immunity against B cell lymphoma. Nature Med 1996; 2: 1038-1041.
10. Hakim I, Levy S, Levy R. A nine amino acid peptide from IL-1b aguments antitumor immune responses induced by protein and DNA vaccines. J Immunol 1996; 157: 5503-5511.
11. King CA et al. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nature Med 1998; 4: 1281-1286.
12. George AJ et al. Monoclonal antibodies raised against the idiotype of the murine B-cell lymphoma BCL1 act primarily with heavy chain determinants. Hybridoma 1991; 10: 219-227.
13. Tao MH, Levy R. Idiotype/granulocyte-macrophage colony stimulating factor fusion protein as a vaccine for B-cell lymphoma. Nature 1993; 362: 755-758.
14. Chen TT, Tao MH, Levy R. Idiotype-cytokine fusion proteins as cancer vaccines. J Immunol 1994; 153: 4775-4780.
15. Kwak LW et al. Vaccination with syngeneic, lymphoma derived immunoglobulin idiotype combined with granulocyte-macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc Natl Acad Sci USA 1996; 93: 10972-10977.
16. Weiss R et al. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol 1998; 161: 2325-2332.
17. Lee PP et al. T-helper 2-dominant antilymphoma immune response is associated with fatal outcome. Blood 1997; 90: 1611-1617.
18. Morecki S et al. Tumor-cell vaccination induces tumor dormancy in a murine model of B cell leukemia/lymphoma (BCL1). Int J Cancer 1996; 65: 204-208.
19. George AJT, Tutt AL, Stevenson FK. Anti-idiotypic mechanism involved in suppression of a mouse B cell lymphoma, BCL1. J Immunol 1987; 138: 628-634.
20. Li E et al. Mammalian cell expression of dimeric small immune proteins (SIP). Protein Eng 1997; 10: 731-736.
21. Watanabe A et al. Induction of antibodies to a k V region by gene immunization. J Immnnol 1993; 151: 2871-2876.
22. Aba A et al. Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy. Gene Theraphy 1996; 3: 988-993.
23. Geissler M et al. Intracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizations. J Virol 1999, 73: 4284-4292.
24. Lewis PJ et al. Altering the cellular location of an antigen expressed by a DNA-based vaccines modulates the immune response. J Virol 1999: 73: 10214-10223.
25. Syrengelas A, Levy R. DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection. J Immunol 1999; 162: 4790-4795.
26. Slavin S, Strobin S. Spontaneous murine B cell leukaemia. Nature 1978; 272: 624-626.
27. Batista FD, Efremov DG, Burrone OR. Characterization of a second secreted igE isoforms and identification of an asymetric pathway of IgE assembly. Proc Natl Acad Sci USA 1996; 93: 3399-3404.